TXMD
TherapeuticsMD Inc.
$2.11
-$0.01(-0.47%)
44
Overall
60
Value
30
Tech
42
Quality
Market Cap
$15.86M
Volume
20.44K
52W Range
$0.98 - $2.95
Target Price
$5.00
Company Overview
| Mkt Cap | $15.86M | Price | $2.11 |
| Volume | 20.44K | Change | -0.47% |
| P/E Ratio | -27.9 | Open | $2.11 |
| Revenue | $4.9M | Prev Close | $2.12 |
| Net Income | $-569.0K | 52W Range | $0.98 - $2.95 |
| Div Yield | N/A | Target | $5.00 |
| Overall | 44 | Value | 60 |
| Quality | 42 | Technical | 30 |
No chart data available
About TherapeuticsMD Inc.
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Sector: Healthcare
Industry: Drug Manufacturers - Major
Latest News
TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives
TipRanks Auto-Generated Newsdesk•14 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TXMD | $2.11 | -0.5% | 20.44K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |